ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Neurology

Top Neurology Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANA ZABAD MD

Neurology

524

$702K

68
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 24%

$1340
Average prescription price

Avg: $242

JOSE AMERICO FERNANDES MD

Neurology

462

$212K

43
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

28%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 24%

$459
Average prescription price

Avg: $242

COLIN SANNER MD

Neurology

3,455

$1.57M

234
110 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$455
Average prescription price

Avg: $242

DEEPAK MADHAVAN MD

Neurology

2,846

$1.28M

171
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 24%

$448
Average prescription price

Avg: $242

GARY PATTEE M.D.

Neurology

1,435

$615K

164
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$429
Average prescription price

Avg: $242

DIEGO TORRES-RUSSOTTO MD

Neurology

608

$216K

63
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$355
Average prescription price

Avg: $242

JAN WEBER M.D.

Neurology

5,357

$1.85M

401
231 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$345
Average prescription price

Avg: $242

JOHN PUENTE M.D.

Neurology

2,687

$878K

290
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$327
Average prescription price

Avg: $242

XIAOMEI GAO-HICKMAN MD

Neurology

2,578

$677K

271
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$263
Average prescription price

Avg: $242

ROBERT STEG MD

Neurology

1,644

$419K

92
49 are 65+

27%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$255
Average prescription price

Avg: $242

LEWISTON BIRKMANN M.D.

Neurology

4,752

$1.18M

484
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$248
Average prescription price

Avg: $242

HAKAM ASAAD MD

Neurology

4,411

$1.08M

461
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$244
Average prescription price

Avg: $242

JAMES BOBENHOUSE M.D.

Neurology

4,664

$1.09M

454
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$233
Average prescription price

Avg: $242

SANJAY SINGH MD

Neurology

1,959

$456K

125
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$233
Average prescription price

Avg: $242

JOSE CARDENAS M.D.

Neurology

2,901

$659K

354
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$227
Average prescription price

Avg: $242

NAJIB MURR MD

Neurology

510

$115K

49
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$226
Average prescription price

Avg: $242

BETTY BALL M.D.

Neurology

1,171

$260K

128
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$222
Average prescription price

Avg: $242

JOHN HANNAM M.D.

Neurology

1,616

$355K

201
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 24%

$219
Average prescription price

Avg: $242

JOEL PARAISO MD

Neurology

691

$148K

110
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$214
Average prescription price

Avg: $242

MATTHEW KNISS M.D.

Neurology

2,588

$548K

258
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$212
Average prescription price

Avg: $242

JOHN AITA MD

Neurology

491

$102K

61
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $242

HARRIS FRANKEL M.D.

Neurology

814

$163K

91
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$200
Average prescription price

Avg: $242

PIERRE FAYAD MD

Neurology

241

$45.7K

31
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 24%

$190
Average prescription price

Avg: $242

DANIEL MURMAN MD

Neurology

2,206

$403K

190
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$183
Average prescription price

Avg: $242

JOHN BERTONI M.D., PH.D.

Neurology

1,974

$357K

179
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$181
Average prescription price

Avg: $242

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank